Clinical Trial

A Study of ZW191 in Participants With Solid Tumors

Active, Not Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
The purpose of this study is to find out if ZW191 is safe and can treat participants with advanced cancers, including ovarian, endometrial, and non-small cell lung cancers.
Protocol Amendment History 1 change
critical Trial status changed: Recruiting → Active, Not Recruiting 2026-04-23
Trial Details
NCT Number NCT06555744
Lead Sponsor Zymeworks BC Inc.
Conditions Advanced Solid Tumors
Enrollment 145 participants
Start Date 2024-10-30
Primary Completion 2026-12 (estimated)
Study Completion 2027-01 (estimated)
Updated on ClinicalTrials.gov 2026-05-07